Graham E. Quinn
Emeritus Professor CE of Ophthalmology
Department: Ophthalmology
Contact information
Division of Pediatric Ophthalmology
The Children's Hospital of Philadelphia
34th & Civic Center Blvd
Philadelphia, PA 19104
The Children's Hospital of Philadelphia
34th & Civic Center Blvd
Philadelphia, PA 19104
Publications
Education:
A.B. (Chemistry)
Duke University, 1969.
M.D.
Duke University School of Medicine, 1973.
M.S.C.E. (Center for Clinical Epidemiology and Biostatistics)
University of Pennsylvania School of Medicine, 2001.
A.B. (Chemistry)
Duke University, 1969.
M.D.
Duke University School of Medicine, 1973.
M.S.C.E. (Center for Clinical Epidemiology and Biostatistics)
University of Pennsylvania School of Medicine, 2001.
Post-Graduate Training
Internship, Cleveland Metropolitan General Hospital Case-Western Reserve University Department of Medicine, 1973-1974.
Residency, Cleveland Metropolitan General Hospital Case-Western Reserve University Department of Pathology, 1974-1975.
Residency, University of Pennsylvania, Scheie Eye Institute, Department of Ophthalmology, 1975-1978.
Fellowship, Pediatric Ophthalmology, Children's Hospital of Philadelphia, 1978-1979.
Permanent linkInternship, Cleveland Metropolitan General Hospital Case-Western Reserve University Department of Medicine, 1973-1974.
Residency, Cleveland Metropolitan General Hospital Case-Western Reserve University Department of Pathology, 1974-1975.
Residency, University of Pennsylvania, Scheie Eye Institute, Department of Ophthalmology, 1975-1978.
Fellowship, Pediatric Ophthalmology, Children's Hospital of Philadelphia, 1978-1979.
Description of Research Expertise
Dr. Quinn is known for his research on retinopathy of prematurity, assessment of visual function and ocular development, and vision screening and treatment of amblyopia in young children. He has helped develop techniques to assess disease or treatment modalities in infants and children who are at risk for developing severe retinopathy of prematurity. An active area of his research revolves around telemedicine and the digital imaging of the neonate ocular fundus while in the neonatal intensive care unit. Dr. Quinn leads a large NEI-funded study of remote evaluation of digital images from premature infants that has resulted in several recent publications.In addition, Dr Quinn is a sought-after participant in international collaborations for the prevention of blindness from retinopathy of prematurity.
Clinical Trials
Dr. Quinn is the Principal Investigator for the multi-center, NEI-funded study, “Telemedicine System for the Evaluating Acute-Phase Retinopathy of Prematurity.”
Keywords
retinopathy of prematurity, telemedicine, blindness prevention, clinical trials, pediatric ophthalmology
Description of Other Expertise
clinical trials, epidemiology, study designDescription of Itmat Expertise
retinopathy of prematurityvisual development
international eye health
Selected Publications
Lepore Domenico, Quinn Graham E, Molle Fernando, Baldascino Antonio, Orazi Lorenzo, Sammartino Maria, Purcaro Velia, Giannantonio Carmen, Papacci Patrizia, Romagnoli Costantino: Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings. Ophthalmology 121(11): 2212-9, Nov 2014.Quinn Graham E, Ying Gui-shuang, Daniel Ebenezer, Hildebrand P Lloyd, Ells Anna, Baumritter Agnieshka, Kemper Alex R, Schron Eleanor B, Wade Kelly: Validity of a telemedicine system for the evaluation of acute-phase retinopathy of prematurity. JAMA ophthalmology 132(10): 1178-84, Oct 2014.
Quinn GE on behalf of the e-ROP Cooperative Group: Telemedicine approaches to evaluating acute-phase retinopathy of prematurity: study design. Ophthalmic epidemiology 21(4): 256-67, Aug 2014.
Quinn Graham E, Fielder Alistair R: Prevention of ROP blindness. Clinics in perinatology 40(2): xvii-xviii, Jun 2013.
Darlow Brian A, Ells Anna L, Gilbert Clare E, Gole Glen A, Quinn Graham E: Are we there yet? Bevacizumab therapy for retinopathy of prematurity. Archives of disease in childhood. Fetal and neonatal edition 98(2): F170-4, Mar 2013.
Binenbaum Gil, Ying Gui-Shuang, Quinn Graham E, Huang Jiayan, Dreiseitl Stephan, Antigua Jules, Foroughi Negar, Abbasi Soraya: The CHOP postnatal weight gain, birth weight, and gestational age retinopathy of prematurity risk model. Archives of ophthalmology 130(12): 1560-5, Dec 2012.
Quinn Graham E, Dobson Velma, Davitt Bradley V, Wallace David K, Hardy Robert J, Tung Betty, Lai Dejian, Good William V: Progression of myopia and high myopia in the Early Treatment for Retinopathy of Prematurity study: findings at 4 to 6 years of age. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus / American Association for Pediatric Ophthalmology and Strabismus 17(2): 124-8, Apr 2013.
Gordillo Luz, Villanueva Ana Maria, Quinn Graham E: A practical method for reducing blindness due to retinopathy of prematurity in a developing country. Journal of perinatal medicine 40(5): 577-82, Sep 2012.
Quinn GE, Dobson V, Repka MX, Reynolds J, Kivlin J, Davis B, Buckley E, Flynn JT, Palmer EA: Development of myopia in infants with birth weights less than 1251g. OPHTHALMOLOGY 99: 329-340, 1992.
Quinn GE, Shin CH, Maguire MG, Stone RA: Myopia and ambient light exposure at night. NATURE 399: 113-114, May 13 1999.
The Committee for the Classification of Retinopathy of Prematurity (ICROP): An international classification of retinopathy of prematurity. Archives of ophthalmology 102(8): 1130-4, Aug 1984.
The International Committee for the Classification of Retinopathy of Prematurity. : The International Classification of Retinopathy of Prematurity revisited. Archives of ophthalmology 123(7): 991-9, Jul 2005.
Quinn G, Gilbert C: Prevention of blindness in children throughout the world: how can we help? Expert Rev Ophthalmol 6(3): 287-290, June 2011.